A type I combi-targeting approach for the design of molecules with enhanced potency against BRCA1/2 mutant- and O6-methylguanine-DNA methyltransferase (mgmt)- expressing tumour cells.

Name: A type I combi-targeting approach for the design of molecules with enhanced potency against BRCA1/2 mutant- and O6-methylguanine-DNA methyltransferase (mgmt)- expressing tumour cells.
Author: Senhaji Mouhri, Zhor

A type I combi-targeting approach for the design of molecules with enhanced potency against BRCA1/2 mutant- and O6-methylguanine-DNA methyltransferase (mgmt)- expressing tumour cells. — المؤلف: Senhaji Mouhri, Zhor — BMC cancer 20180503

المؤلف: Senhaji Mouhri, Zhor
النشر: BMC cancer 20180503
الوصف: 540 p.
الموضوعات: Animals؛ Antineoplastic Combined Chemotherapy Protocols؛ BRCA1 Protein؛ BRCA2 Protein؛ Cell Line, Tumor؛ Cricetulus؛ DNA Repair؛ DNA, Neoplasm